Alexander Stebner
Overview
Explore the profile of Alexander Stebner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
4
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bosshart S, Stebner A, Zerna C, Harrison E, Kleinig T, Puetz V, et al.
Can J Neurol Sci
. 2025 Mar;
:1-19.
PMID: 40071549
No abstract available.
2.
Stebner A, Bosshart S, Fujiwara S, Souza R, Bento M, Ospel J
Interv Neuroradiol
. 2025 Feb;
:15910199251323117.
PMID: 40012538
Acute ischemic stroke occurs when a blood clot obstructs cerebral blood flow, leading to ischemia and potentially irreversible brain damage. While large vessel occlusions are known for their catastrophic effects,...
3.
Ospel J, Brown S, Bosshart S, Stebner A, Uchida K, Demchuk A, et al.
J Am Heart Assoc
. 2025 Feb;
14(5):e037752.
PMID: 39968801
Background: We investigate whether the National Institutes of Health Stroke Scale (NIHSS) at 24 hours could serve as a primary outcome in acute ischemic stroke trials, and whether combining 90-day...
4.
Christenson J, Hill M, Swartz R, Adams C, Benavente O, Casaubon L, et al.
Lancet
. 2025 Feb;
405(10478):571-582.
PMID: 39955120
Background: Nerinetide is a neuroprotectant effective in preclinical models of acute ischaemic stroke when administered within 3 h of onset. However, the clinical evaluation of neuroprotectants in this short timeframe...
5.
Pensato U, Bosshart S, Stebner A, Dowlatshahi D, Bang O, Sahlas D, et al.
Stroke
. 2025 Feb;
56(3):657-666.
PMID: 39925291
Background: Infarct growth rate is remarkably heterogeneous in acute ischemic stroke, reflecting diverse clinical-physiological phenotypes. We compared different methods of estimating infarct growth rate in patients with acute ischemic stroke...
6.
Goyal M, Ospel J, Ganesh A, Dowlatshahi D, Volders D, Mohlenbruch M, et al.
N Engl J Med
. 2025 Feb;
PMID: 39908448
Background: Whether the large effect size of endovascular thrombectomy (EVT) for stroke due to large-vessel occlusion applies to stroke due to medium-vessel occlusion is unclear. Methods: In a multicenter, prospective,...
7.
Uchida K, Bosshart S, Stebner A, Almekhlafi M, Demchuk A, Ganesh A, et al.
J Neurol Sci
. 2024 Nov;
467:123316.
PMID: 39580929
Background: Carotid plaques may be an important etiology in ischemic stroke. We aimed to assess carotid plaque characteristics ipsilateral and contralateral to the ischemic stroke and assessed the prevalence of...
8.
Pensato U, Bosshart S, Stebner A, Rohr A, Kleinig T, Gupta R, et al.
Neurology
. 2024 Oct;
103(10):e209939.
PMID: 39432874
Background And Objectives: CT perfusion (CTP) maps can estimate the ischemic core in acute ischemic stroke based on distinctive cerebral blood flow thresholds. However, metabolic factors beyond perfusion influence the...
9.
Stebner A, Bosshart S, Demchuk A, Poppe A, Nogueira R, McTaggart R, et al.
Clin Neuroradiol
. 2024 Oct;
35(1):141-150.
PMID: 39404848
Purpose: The modified Rankin Scale (mRS) at 90 days is the primary outcome in most acute stroke studies, but the long follow-up period has disadvantages. The National Institutes of Health...
10.
Bosshart S, Stebner A, Weyland C, Radu R, Ospel J
J Neurointerv Surg
. 2024 Oct;
PMID: 39379317
Background: Surveys are increasingly used in neurointervention to gauge physicians' and patients' attitudes, practice patterns, and 'real-world' treatment strategies, particularly in conditions for which few, or no evidence-based, recommendations exist....